As of Aug 16
| -0.07 / -4.76%|
The 1 analysts offering 12-month price forecasts for MusclePharm Corp have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +185.71% increase from the last price of 1.40.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.